Msd announced today that the European Commission has approved pembrolizumab in combination with enfortumab vedotin, as neoadjuvant treatment and subsequently, after radical cystectomy, as adjuvant ...
A new trial has opened in Verona for David Sirca, the so-called 'Acquabomber'. The 51-year-old computer scientist from Trieste is accused of attempted extortion against the food group Zuegg. According ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results